BDC delivers strong Quotient exit
Bridgepoint Development Capital (BDC) has sold its pharmaceuticals business Quotient Clinical to GHO Capital.
It is understood that the deal values Quotient at £165m (€234.3m)
Bridgepoint Development Capital (BDC) has sold its pharmaceuticals business Quotient Clinical to GHO Capital.
It is understood that the deal values Quotient at £165m (€234.3m)